financial post
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
Financial Post • 2 MONTHS AGO
Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon
Financial Post • 2 MONTHS AGO
Dawn Project testing of Tesla Full Self-Driving vindicated by Tesla supporter
Financial Post • 2 MONTHS AGO
Bike New York & Let’s Do This Announce New Partnership to Enhance Registration Experience for Riders
Financial Post • 2 MONTHS AGO
Moody’s downgrades Mexican government’s outlook to ‘negative’ over weakening of judiciary and debt
Financial Post • 2 MONTHS AGO